SCHEMBL27285050

SCHEMBL27285050

Cc1nnc(C)c2c1ncn2C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 3/20 0.35
▸ ADORA1 P30542 2/20 0.35
▸ GDA Q9Y2T3 2/20 0.34
▸ ADORA2B P29275 2/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ NTSR1 P30989 1/20 0.34
▸ MC3R P41968 1/20 0.34
▸ NOTUM Q6P988 1/20 0.34
▸ SIRT3 Q9NTG7 1/20 0.34
▸ NR2E1 Q9Y466 1/20 0.34
▸ IKBKB O14920 4/20 0.33
▸ CHUK O15111 4/20 0.33
▸ YTHDC1 Q96MU7 2/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ PLK1 P53350 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23122695 0.84 HPGD (0.38) ADORA2AADORA1GDAADORA2BPIK3CD
SCHEMBL23122489 0.81 CACNA2D1 (0.33) ADORA2AADORA1ALDH1A1PDE4APDE4B
SCHEMBL20200121 0.71 AHCY (0.33) ADORA2AADORA1GDAADORA2BPIK3CD
SCHEMBL23122556 0.69 GDA (0.46) ADORA2AADORA1GDAADORA2BPIK3CD
SCHEMBL8737256 0.68 IKBKB (0.36) ADORA2AADORA1GDAADORA2BPIK3CD
SCHEMBL13348729 0.67 CDK1 (0.37) ADORA2AADORA1IKBKBCHUKCDK2
SCHEMBL23122432 0.67 CDK1 (0.39) ADORA2AADORA1GDAADORA2BPIK3CD
SCHEMBL20203177 0.66 PIK3CD (0.37) ADORA2AADORA1GDAADORA2BPIK3CD
SCHEMBL15339546 0.65 LMNA (0.35) ADORA2AADORA1GDAADORA2BPIK3CD
SCHEMBL8737240 0.65 LMNA (0.33) ADORA2AADORA1POLBIKBKBCHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024006559-A1 MODULATORS OF NLRP3 INFLAMMASOME AND RELATED PRODUCTS AND METHODS Neumora Therapeutics, Inc. (US) 2024-01-04 — — WO disclosed
Send feedback